• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在低氧和营养条件下,有无免疫隔离胶囊和坏死抑制剂-1时人胰岛产生的内源性危险信号

DAMP production by human islets under low oxygen and nutrients in the presence or absence of an immunoisolating-capsule and necrostatin-1.

作者信息

Paredes-Juarez Genaro A, Sahasrabudhe Neha M, Tjoelker Reina S, de Haan Bart J, Engelse Marten A, de Koning Eelco J P, Faas Marijke M, de Vos Paul

机构信息

University of Groningen, University Medical Center Groningen, Department of Pathology and Medical Biology, Section of Immunoendocrinology, Groningen, 9713 GZ, The Netherlands.

Department of Nephrology, Leiden University Medical Center, Leiden, 2300 RC, The Netherlands.

出版信息

Sci Rep. 2015 Sep 30;5:14623. doi: 10.1038/srep14623.

DOI:10.1038/srep14623
PMID:26419792
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4588515/
Abstract

In between the period of transplantation and revascularization, pancreatic islets are exposed to low-oxygen and low-nutrient conditions. In the present study we mimicked those conditions in vitro to study the involvement of different cell death processes, release of danger-associated molecular patterns (DAMP), and associated in vitro immune activation. Under low-oxygen and low-nutrient conditions, apoptosis, autophagy and necroptosis occur in human islets. Necroptosis is responsible for DAMP-release such as dsDNA, uric acid, and HMGB1. The sensors of the innate immune system able to recognize these DAMPs are mainly TLR, NOD receptors, and C-type lectins. By using cell-lines with a non-functional adaptor molecule MyD88, we were able to show that the islet-derived DAMPs signal mainly via TLR. Immunoisolation in immunoprotective membranes reduced DAMP release and immune activation via retention of the relative large DAMPs in the capsules. Another effective strategy was suppressing necroptosis using the inhibitor nec-1. Although the effect on cell-survival was minor, nec-1 was able to reduce the release of HMGB1 and its associated immune activation. Our data demonstrate that in the immediate post-transplant period islets release DAMPs that in vitro enhance responses of innate immune cells. DAMP release can be reduced in vitro by immunoisolation or intervention with nec-1.

摘要

在移植期和血管重建期之间,胰岛会暴露于低氧和低营养环境中。在本研究中,我们在体外模拟这些条件,以研究不同细胞死亡过程的参与情况、危险相关分子模式(DAMP)的释放以及相关的体外免疫激活。在低氧和低营养条件下,人胰岛会发生凋亡、自噬和坏死性凋亡。坏死性凋亡负责释放如双链DNA、尿酸和高迁移率族蛋白B1(HMGB1)等DAMP。能够识别这些DAMP的先天免疫系统传感器主要是Toll样受体(TLR)、核苷酸结合寡聚化结构域(NOD)受体和C型凝集素。通过使用具有无功能衔接分子髓样分化因子88(MyD88)的细胞系,我们能够证明胰岛来源的DAMP主要通过TLR发出信号。免疫保护膜中的免疫隔离通过将相对较大的DAMP保留在胶囊中减少了DAMP释放和免疫激活。另一种有效策略是使用抑制剂nec-1抑制坏死性凋亡。尽管对细胞存活的影响较小,但nec-1能够减少HMGB1的释放及其相关的免疫激活。我们的数据表明,在移植后的即刻,胰岛会释放DAMP,这些DAMP在体外增强先天免疫细胞的反应。通过免疫隔离或用nec-1干预,可在体外减少DAMP释放。

相似文献

1
DAMP production by human islets under low oxygen and nutrients in the presence or absence of an immunoisolating-capsule and necrostatin-1.在低氧和营养条件下,有无免疫隔离胶囊和坏死抑制剂-1时人胰岛产生的内源性危险信号
Sci Rep. 2015 Sep 30;5:14623. doi: 10.1038/srep14623.
2
Inclusion of extracellular matrix molecules and necrostatin-1 in the intracapsular environment of alginate-based microcapsules synergistically protects pancreatic β cells against cytokine-induced inflammatory stress.在藻酸盐微胶囊的囊内环境中加入细胞外基质分子和坏死抑制素-1,协同保护胰岛 β 细胞免受细胞因子诱导的炎症应激。
Acta Biomater. 2022 Jul 1;146:434-449. doi: 10.1016/j.actbio.2022.04.042. Epub 2022 Apr 30.
3
Necrostatin-1 supplementation enhances young porcine islet maturation and in vitro function.Necrostatin-1 补充剂增强年轻猪胰岛的成熟和体外功能。
Xenotransplantation. 2020 Jan;27(1):e12555. doi: 10.1111/xen.12555. Epub 2019 Sep 18.
4
High mobility group box 1 secretion blockade results in the reduction of early pancreatic islet graft loss.高迁移率族蛋白 B1 封锁可减少早期胰岛移植物的丢失。
Biochem Biophys Res Commun. 2019 Jul 5;514(4):1081-1086. doi: 10.1016/j.bbrc.2019.05.003. Epub 2019 May 14.
5
Dose-dependent effects of necrostatin-1 supplementation to tissue culture media of young porcine islets.补充 Necrostatin-1 对幼猪胰岛组织培养物的剂量依赖性作用。
PLoS One. 2020 Dec 7;15(12):e0243506. doi: 10.1371/journal.pone.0243506. eCollection 2020.
6
Hypoxia/reoxygenation-induced HMGB1 translocation and release promotes islet proinflammatory cytokine production and early islet graft failure through TLRs signaling.缺氧/复氧诱导的高迁移率族蛋白 B1 易位和释放通过 TLRs 信号促进胰岛前炎性细胞因子的产生和早期胰岛移植物失功。
Biochim Biophys Acta Mol Basis Dis. 2017 Feb;1863(2):354-364. doi: 10.1016/j.bbadis.2016.11.012. Epub 2016 Nov 10.
7
Applying Immunomodulation to Promote Longevity of Immunoisolated Pancreatic Islet Grafts.应用免疫调节促进免疫隔离胰岛移植物的长期存活。
Tissue Eng Part B Rev. 2022 Feb;28(1):129-140. doi: 10.1089/ten.TEB.2020.0326. Epub 2021 Feb 24.
8
Necrostatin-1 suppresses autophagy and apoptosis in mice traumatic brain injury model.Necrostatin-1 抑制小鼠创伤性脑损伤模型中的自噬和细胞凋亡。
Neurochem Res. 2012 Sep;37(9):1849-58. doi: 10.1007/s11064-012-0791-4. Epub 2012 Jun 27.
9
Laminin and collagen IV inclusion in immunoisolating microcapsules reduces cytokine-mediated cell death in human pancreatic islets.免疫隔离微囊中的层粘连蛋白和胶原 IV 包含物减少了人胰腺胰岛细胞中细胞因子介导的细胞死亡。
J Tissue Eng Regen Med. 2018 Feb;12(2):460-467. doi: 10.1002/term.2472. Epub 2017 Sep 18.
10
Pretreatment of donor islets with the Na(+) /Ca(2+) exchanger inhibitor improves the efficiency of islet transplantation.用钠离子/钙离子交换器抑制剂预处理供体胰岛可提高胰岛移植的效率。
Am J Transplant. 2013 Aug;13(8):2154-60. doi: 10.1111/ajt.12306. Epub 2013 Jun 7.

引用本文的文献

1
Heparan sulfate fine-tuned interleukin-1 (IL-1) signaling inhibits insulin secretion of grafted pancreatic islets.硫酸乙酰肝素微调白细胞介素-1(IL-1)信号传导抑制移植胰岛的胰岛素分泌。
Sci Adv. 2025 Aug 8;11(32):eady8566. doi: 10.1126/sciadv.ady8566.
2
Inhibition of polymorphonuclear cells averts cytotoxicity against hypoimmune cells in xenotransplantation.抑制多形核细胞可避免异种移植中对免疫低下细胞的细胞毒性。
Nat Commun. 2025 Apr 18;16(1):3706. doi: 10.1038/s41467-025-58774-7.
3
Mesenchymal Stem/Stromal Cells Microencapsulation for Cell Therapy.

本文引用的文献

1
A Technology Platform to Test the Efficacy of Purification of Alginate.一个用于测试藻酸盐纯化效果的技术平台。
Materials (Basel). 2014 Mar 12;7(3):2087-2103. doi: 10.3390/ma7032087.
2
Immunological and technical considerations in application of alginate-based microencapsulation systems.海藻酸盐基微囊化系统应用中的免疫学和技术考虑因素。
Front Bioeng Biotechnol. 2014 Aug 6;2:26. doi: 10.3389/fbioe.2014.00026. eCollection 2014.
3
Mesenchymal stem cells help pancreatic islet transplantation to control type 1 diabetes.间充质干细胞有助于胰岛移植以控制1型糖尿病。
用于细胞治疗的间充质干/基质细胞微囊化
Cells. 2025 Jan 21;14(3):149. doi: 10.3390/cells14030149.
4
Pancreatic stellate cells support human pancreatic β-cell viability and enhance survival of immunoisolated human islets exposed to cytokines.胰腺星状细胞维持人胰腺β细胞的活力,并提高暴露于细胞因子的免疫隔离人胰岛的存活率。
Mater Today Bio. 2024 Jun 18;27:101129. doi: 10.1016/j.mtbio.2024.101129. eCollection 2024 Aug.
5
RISING STARS: Evidence for established and emerging forms of β-cell death.新星崛起:β细胞死亡的既定形式和新兴形式的证据。
J Endocrinol. 2024 Jul 4;262(2). doi: 10.1530/JOE-23-0378. Print 2024 Aug 1.
6
Extracellular matrix stiffness mediates insulin secretion in pancreatic islets via mechanosensitive Piezo1 channel regulated Ca dynamics.细胞外基质硬度通过机械敏感的Piezo1通道调节的钙动力学介导胰岛中的胰岛素分泌。
Matrix Biol Plus. 2024 May 17;22:100148. doi: 10.1016/j.mbplus.2024.100148. eCollection 2024 Jun.
7
Absent in Melanoma (AIM)2 Promotes the Outcome of Islet Transplantation by Repressing Ischemia-Induced Interferon (IFN) Signaling.AIM2 在黑色素瘤中缺失可通过抑制缺血诱导的干扰素(IFN)信号转导来改善胰岛移植的预后。
Cells. 2023 Dec 20;13(1):16. doi: 10.3390/cells13010016.
8
Cell Replacement Therapy for Type 1 Diabetes Patients: Potential Mechanisms Leading to Stem-Cell-Derived Pancreatic β-Cell Loss upon Transplant.1 型糖尿病患者的细胞替代治疗:移植后干细胞源性胰腺 β 细胞丢失的潜在机制。
Cells. 2023 Feb 22;12(5):698. doi: 10.3390/cells12050698.
9
Co-transplantation of pancreatic islets and microvascular fragments effectively restores normoglycemia in diabetic mice.胰岛与微血管片段的联合移植可有效恢复糖尿病小鼠的正常血糖水平。
NPJ Regen Med. 2022 Nov 4;7(1):67. doi: 10.1038/s41536-022-00262-3.
10
A predictive computational platform for optimizing the design of bioartificial pancreas devices.用于优化生物人工胰腺设备设计的预测性计算平台。
Nat Commun. 2022 Oct 13;13(1):6031. doi: 10.1038/s41467-022-33760-5.
World J Stem Cells. 2014 Apr 26;6(2):163-72. doi: 10.4252/wjsc.v6.i2.163.
4
Survival of free and encapsulated human and rat islet xenografts transplanted into the mouse bone marrow.移植到小鼠骨髓中的游离和封装的人及大鼠胰岛异种移植物的存活情况。
PLoS One. 2014 Mar 13;9(3):e91268. doi: 10.1371/journal.pone.0091268. eCollection 2014.
5
Oxygen supply to encapsulated therapeutic cells.包裹治疗细胞的氧气供应。
Adv Drug Deliv Rev. 2014 Apr;67-68:93-110. doi: 10.1016/j.addr.2014.02.007. Epub 2014 Feb 27.
6
Treating diabetes with islet transplantation: lessons from the past decade in Lille.胰岛移植治疗糖尿病:来自里尔过去十年的经验教训。
Diabetes Metab. 2014 Apr;40(2):108-19. doi: 10.1016/j.diabet.2013.10.003. Epub 2014 Feb 6.
7
Polymers in cell encapsulation from an enveloped cell perspective.从包膜细胞的角度看细胞包封中的聚合物。
Adv Drug Deliv Rev. 2014 Apr;67-68:15-34. doi: 10.1016/j.addr.2013.11.005. Epub 2013 Nov 22.
8
Revascularization of transplanted pancreatic islets and role of the transplantation site.移植胰岛的血管重建及移植部位的作用
Clin Dev Immunol. 2013;2013:352315. doi: 10.1155/2013/352315. Epub 2013 Sep 9.
9
The role of pathogen-associated molecular patterns in inflammatory responses against alginate based microcapsules.病原体相关分子模式在针对藻酸盐微胶囊的炎症反应中的作用。
J Control Release. 2013 Dec 28;172(3):983-92. doi: 10.1016/j.jconrel.2013.09.009. Epub 2013 Sep 17.
10
Encapsulated islets for diabetes therapy: history, current progress, and critical issues requiring solution.用于糖尿病治疗的胰岛细胞封装:历史、当前进展和需要解决的关键问题。
Adv Drug Deliv Rev. 2014 Apr;67-68:35-73. doi: 10.1016/j.addr.2013.07.018. Epub 2013 Aug 1.